Total dose of twice daily thoracic irradiation and the use of concomitant chemotherapy may be important determinants of outcome for limited stage small-cell lung cancer
J. Armstrong, M. Rosenstein, M. Kris, B. Shank, H. Scher, D. Fass, L. Harrison, S. Leibel, Z. FuksVolume:
19
Year:
1990
Language:
english
DOI:
10.1016/0360-3016(90)90896-r
File:
PDF, 112 KB
english, 1990